Modeling the Altered Expression Levels of Genes on Signaling Pathways in Tumors as Causal Bayesian Networks

This paper concerns a study indicating that the expression levels of genes in signaling pathways can be modeled using a causal Bayesian network (BN) that is altered in tumorous tissue. These results open up promising areas of future research that can help identify driver genes and therapeutic target...

Full description

Bibliographic Details
Main Authors: Richard Neapolitan, Diyang Xue, Xia Jiang
Format: Article
Language:English
Published: SAGE Publishing 2014-01-01
Series:Cancer Informatics
Online Access:https://doi.org/10.4137/CIN.S13578
_version_ 1818495169822982144
author Richard Neapolitan
Diyang Xue
Xia Jiang
author_facet Richard Neapolitan
Diyang Xue
Xia Jiang
author_sort Richard Neapolitan
collection DOAJ
description This paper concerns a study indicating that the expression levels of genes in signaling pathways can be modeled using a causal Bayesian network (BN) that is altered in tumorous tissue. These results open up promising areas of future research that can help identify driver genes and therapeutic targets. So, it is most appropriate for the cancer informatics community. Our central hypothesis is that the expression levels of genes that code for proteins on a signal transduction network (STP) are causally related and that this causal structure is altered when the STP is involved in cancer. To test this hypothesis, we analyzed 5 STPs associated with breast cancer, 7 STPs associated with other cancers, and 10 randomly chosen pathways, using a breast cancer gene expression level dataset containing 529 cases and 61 controls. We identified all the genes related to each of the 22 pathways and developed separate gene expression datasets for each pathway. We obtained significant results indicating that the causal structure of the expression levels of genes coding for proteins on STPs, which are believed to be implicated in both breast cancer and in all cancers, is more altered in the cases relative to the controls than the causal structure of the randomly chosen pathways.
first_indexed 2024-12-10T18:16:49Z
format Article
id doaj.art-d8277bac3e7d40f98d1859641e2353fe
institution Directory Open Access Journal
issn 1176-9351
language English
last_indexed 2024-12-10T18:16:49Z
publishDate 2014-01-01
publisher SAGE Publishing
record_format Article
series Cancer Informatics
spelling doaj.art-d8277bac3e7d40f98d1859641e2353fe2022-12-22T01:38:19ZengSAGE PublishingCancer Informatics1176-93512014-01-011310.4137/CIN.S13578Modeling the Altered Expression Levels of Genes on Signaling Pathways in Tumors as Causal Bayesian NetworksRichard Neapolitan0Diyang Xue1Xia Jiang2Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.This paper concerns a study indicating that the expression levels of genes in signaling pathways can be modeled using a causal Bayesian network (BN) that is altered in tumorous tissue. These results open up promising areas of future research that can help identify driver genes and therapeutic targets. So, it is most appropriate for the cancer informatics community. Our central hypothesis is that the expression levels of genes that code for proteins on a signal transduction network (STP) are causally related and that this causal structure is altered when the STP is involved in cancer. To test this hypothesis, we analyzed 5 STPs associated with breast cancer, 7 STPs associated with other cancers, and 10 randomly chosen pathways, using a breast cancer gene expression level dataset containing 529 cases and 61 controls. We identified all the genes related to each of the 22 pathways and developed separate gene expression datasets for each pathway. We obtained significant results indicating that the causal structure of the expression levels of genes coding for proteins on STPs, which are believed to be implicated in both breast cancer and in all cancers, is more altered in the cases relative to the controls than the causal structure of the randomly chosen pathways.https://doi.org/10.4137/CIN.S13578
spellingShingle Richard Neapolitan
Diyang Xue
Xia Jiang
Modeling the Altered Expression Levels of Genes on Signaling Pathways in Tumors as Causal Bayesian Networks
Cancer Informatics
title Modeling the Altered Expression Levels of Genes on Signaling Pathways in Tumors as Causal Bayesian Networks
title_full Modeling the Altered Expression Levels of Genes on Signaling Pathways in Tumors as Causal Bayesian Networks
title_fullStr Modeling the Altered Expression Levels of Genes on Signaling Pathways in Tumors as Causal Bayesian Networks
title_full_unstemmed Modeling the Altered Expression Levels of Genes on Signaling Pathways in Tumors as Causal Bayesian Networks
title_short Modeling the Altered Expression Levels of Genes on Signaling Pathways in Tumors as Causal Bayesian Networks
title_sort modeling the altered expression levels of genes on signaling pathways in tumors as causal bayesian networks
url https://doi.org/10.4137/CIN.S13578
work_keys_str_mv AT richardneapolitan modelingthealteredexpressionlevelsofgenesonsignalingpathwaysintumorsascausalbayesiannetworks
AT diyangxue modelingthealteredexpressionlevelsofgenesonsignalingpathwaysintumorsascausalbayesiannetworks
AT xiajiang modelingthealteredexpressionlevelsofgenesonsignalingpathwaysintumorsascausalbayesiannetworks